tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kostas Biliouris, 77 are a BUY (74.04%), 27 are a HOLD (25.96%).
Analyst Kostas Biliouris, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 33.56% that have a potential upside of 35.51% achieved within 115 days. Previously, Kostas Biliouris worked at BMO.
Kostas Biliouris’s has documented 215 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 19-Mar-2026.
Analyst best performing recommendations are on BEAM (BEAM THERAPEUTICS ).
The best stock recommendation documented was for BEAM (BEAM THERAPEUTICS ) at 7/18/2022. The price target of $61 was fulfilled within 1 day with a profit of $2.99 (5.15%) receiving and performance score of 51.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Mar-2020
$65
$40.37 (163.91%)
$57
26 days ago
(25-Feb-2026)
3/8 (37.5%)
$35.84 (122.91%)
154
Hold Since 03-May-2021
$26
$1.37 (5.56%)
$20
26 days ago
(25-Feb-2026)
9/10 (90%)
$-3.16 (-10.84%)
52
Hold Since 08-Dec-2023
$28
$3.37 (13.68%)
$30
2 months 16 days ago
(07-Jan-2026)
4/4 (100%)
$-0.93 (-3.21%)
133
Buy Since 23-Jul-2024
$80
$55.37 (224.81%)
$80
5 months 13 days ago
(10-Oct-2025)
0/9 (0%)
$53.68 (203.95%)
Buy Since 12-Mar-2025
7 months 4 days ago
(19-Aug-2025)
1/10 (10%)
$12.38 (46.51%)
118
Which stock is Kostas Biliouris is most bullish on?
Which stock is Kostas Biliouris is most reserved on?
What Year was the first public recommendation made by Kostas Biliouris?
